|
Special Delegation of the ICF-BSE College of Fellows to Travel to China in April
A special delegation of the International College of Fellows, Biomaterials Science and Engineering (ICF-BSE) has been established to travel to China in April 2010 provide informal advice and guidance to successfully organize the 9th World Biomaterials Congress, to be held in June 2012 in Chengdu.
The Fellows Delegation will also meet with Chinese Fellows to promote cooperation and an international Fellows exchange.
More details regarding the event will be announced.
We welcome the newest members of the ICF-BSE:
Mauli Agrawal Mitsuru Akashi Laurence Bordenave Lisa Brannon-Peppas Joost de Bruijn Jan Chlopek Bum-Koo Cho I-Ming Chu Jong-Pyung Chung Lutz Claes Arthur (Art) Coury Fuzhai Cui Guy Daculsi Avi Domb Eugene Goldberg David Grainger Dirk Grijpma P. (Thilak) Gunatillake Hoon Han Takao Hanawa
|
Yoshiro Hayashi Ging-Ho Hsiue Nan Huang Lynn L.-H. Huang Seo-Young Jeong Lynne Jones Inn-Kyu Kang Minna Kellomaki Dae-Joon Kim Kyo-Han Kim Akio Kishida Ivars Knets Martine LaBerge Doo-Sung Lee Yang Leng Jui-Che Lin Andrew Lloyd Mizuo Maeda Anne Meyer Ajit Nair |
Katsuhiko Nakamae Paolo Netti Dong-Kyun Rah Chandra P Sharma Molly Shoichet Paulette Spencer Hsing-Wen Sung Yasuhiko Tabata Maria Cristina Tanzi Pentti Tengvall Hasan Uludag William Wagner Yingjun Wang Kimberly (Kim) Woodhouse Kimihiro Yamashita Heimo Ylanen Takayuki Yoneyama Nobuhiko Yui |
The ICF-BSE College of Fellows Special Session Programme at the 2008 World Biomaterials Congress, Amsterdam
Critical changes in biomaterials science: Presented on behalf of the ICF-BSE Steering Committee. Joachim Kohn, Chair
|
Biological Interactions at the Nanoscale: How far can we go in mimicking nature? Buddy Ratner |
Twenty-first century biological methods in biomaterials research. Peter Revell |
Beyond the foreign body response: Understanding the mechanism of the host response to biomaterial implants. Michael Sefton |
The Debate:
Topic: This House Believes that the Preclinical Testing of New Biomaterials is a Waste of Time.
Moderated by: David Williams
Every biomaterial introduced into commerce and clinical practice has to be assessed for biological safety, typically through a series of pre-clinical in vitro and in vivo procedures, for example those promulgated through ISO 10993. However, there is very good evidence to show that neither in vitro or in vivo tests are predictive of clinical performance and that many materials that pass the tests ultimately fail in some applications, whilst others that fail the test may have posed no risk to patients.
This debate, following the traditional format of debates, included arguments for and against the proposition, two from each side. No visual aids were used, the speakers were required to keep exactly to time. |
Debaters:
David Grainger USA
For the Motion First Proposer |
Peter Zilla South Africa
Against the Motion First Opposer
|
| |
|
Sarah Cartmell UK
For the Motion Second Proposer |
Tom Barker USA
Against the Motion Second Opposer
|
|
|